**File title:**
Qiagen takeover scenarios and industry speculation notes

update 1

Oh, fun. Thermo Fisher Scientific made a couple of offers for QIAGEN back in 2019 but an activist investor killed it. CEO Thierry is retiring so ideal situation for a deal that could close this time. Usual other suspects are Danaher Corporation, Agilent Technologies and bioMÃ©rieux.

BUT BUT BUT how about Illumina, this would fit perfectly with Jacob's vision for total vertical NGS integration from sample to answer ğŸ¤¯ğŸ¤¯ğŸ¤¯

update 2
Ha! Credible source tells me they saw Illumina's Jacob Thaysen walking around with Peer Schatz, QIAGEN's ex-CEO at JPM last week. Quite the coincidence ğŸ˜…ğŸ˜…ğŸ˜…


update 3
Or, maybe Roche buys QIAGEN to complement SBX, and to keep it away from Illumina. Probably no antitrust issues, EU happy.

Endless possibilities ğŸ‘ğŸ‘ğŸ‘
